| SEQUENCE: RAFL05-16-K10_1_ORF2 CRC64: E946ACDE48FCA5C7 LENGTH: 505 aa | ||||||||||
| InterPro IPR012335 Domain |
| |||||||||
| InterPro IPR012336 Domain |
| |||||||||
| InterPro IPR012936 Domain |
| |||||||||
| InterPro IPR013766 Domain |
| |||||||||
| InterPro IPR017936 Domain |
| |||||||||
| noIPR unintegrated |
| |||||||||
| SEQUENCE: RAFL05-16-K10_2_ORF1 CRC64: C534D31057D2D112 LENGTH: 68 aa | |||||||
| noIPR unintegrated |
| ||||||
| SEQUENCE: RAFL05-16-K10_2_ORF2 CRC64: 7E215E356FF9FF9E LENGTH: 52 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_3_ORF2 CRC64: C9D5D292AA1DDA2B LENGTH: 69 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_4_ORF1 CRC64: 2C53CFE9BB7FF57B LENGTH: 49 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_4_ORF2 CRC64: 29A5E149752FE89E LENGTH: 99 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_4_ORF3 CRC64: 31039B37BD22A062 LENGTH: 69 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_5_ORF2 CRC64: 122695AD4D3D1A4F LENGTH: 58 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_5_ORF3 CRC64: 2AF23BB136F62CAF LENGTH: 51 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_5_ORF4 CRC64: 45D1EFD0C2CECA72 LENGTH: 59 aa | |
| No hits reported. |
| SEQUENCE: RAFL05-16-K10_6_ORF2 CRC64: E2E0E08EE8F063FE LENGTH: 107 aa | |
| No hits reported. |
![[157-288]T 3.8e-18 G3DSA:3.40.30.10 no description](http://pmix.psc.riken.jp/img/interpro/X2.gif){kind=small}
![[162-289]T 2e-24 SSF52833 Thioredoxin-like](http://pmix.psc.riken.jp/img/interpro/B.gif){kind=small}
![[313-486]T 3.4e-27 PF07970 COPIIcoated_ERV](http://pmix.psc.riken.jp/img/interpro/H.gif){kind=small}
![[155-285]T 10.271 PS51352 THIOREDOXIN_2](http://pmix.psc.riken.jp/img/interpro/M.gif){kind=small}
![[28-504]T 1.2e-303 PTHR10984 SEROLOGICALLY DEFINED BREAST CANCER ANTIGEN NY-BR-84-RELATED](http://pmix.psc.riken.jp/img/interpro/X4.gif){kind=small}
![[34-49]? NA seg seg](http://pmix.psc.riken.jp/img/interpro/G.gif){kind=small}